Surfactant dysfunction may contribute to the development of bronchopulmonary dysplasia (BPD) in persistently ventilated preterm infants. We conducted a multicenter randomized, blinded, pilot study to ...
An article published in Experimental Biology and Medicine (Volume 242, Issue 13, July, 2017) reports that gene therapy may be used to as an intermediate therapy for newborns with surfactant protein ...
Bronchopulmonary dysplasia (BPD) remains the most common respiratory complication of very preterm infants. Its pathogenesis recognizes multiple factors, such as prenatal infection, lung immaturity, ...
The innovation—a handheld dry powder inhaler for newborns in respiratory distress—recently cleared a proof-of-concept milestone, with results published in a peer-reviewed journal. Now, inventors ...
Surfactant therapy has become a routine for neonatal respiratory care and already proved to reduce morbidity and mortality in neonatal respiratory distress syndrome. The surfactant replacement has ...
A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for infants on life support with severe bronchiolitis — a seasonal viral ...
The MarketWatch News Department was not involved in the creation of this content. AlveoGene's Novel, Inhaled Gene Therapy AVG-002 Receives Orphan Drug Designation from FDA for Lethal Neonatal ...
Babies with bronchiolitis have reduced levels of surfactant in their lungs, a condition similar to that seen in babies born prematurely. Because surfactant is routinely used to help premature infants ...
Researchers conducted a meta-analysis of 12 randomized controlled trials involving 2428 premature infants, comparing intratracheal budesonide plus pulmonary surfactant with pulmonary surfactant alone.
A team led by University of Minnesota Twin Cities engineering researchers analyzed the fundamental properties and structures of lung surfactant - a naturally occurring substance that helps human and ...
CHICAGO -- Use of endotracheal poractant alfa (Curosurf) did not shorten the duration of invasive mechanical ventilation for infants with bronchiolitis, a randomized phase II trial indicated. The ...
We are at a critical time and supporting climate journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen environmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results